3Liver Failure and Artficial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association.肝衰竭诊疗指南[J].实用肝脏病杂志,2006,9(6):321-324. 被引量：188
7Honkoop P,De Man RA.Entecavir:a potent new antiviral drug for hepatitis B.Expert Opin Investig Drugs,2003,12:683-688.
8Shaw T,Locarnini S.Entecavir for the treatment of chronic hepatitis B.Expert Rev Anti Infect Ther,2004,2:853-871.
9DeHertogh D,Colonno R,Fiske W,et al.Development of entecavir:superior therapy for the management of chronic hepatitis B viral infection.In:Omata M,Okita K.Therapy for viral hepatitis and prevention of hepatocellular carcinoma.Tokyo:Spring-Verlag,2004.63-73.
10Lai CL,Rosmawati M,Lao J,et al.Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.Gastroenterology,2002,123:1831-1838.
2Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
5Nevens F, Laleman W. Artificial liver support devices as treatment option for liver failure [ J ]. Best Pract Res Clin Gastroenterol, 2012, 26(1) : 17-26.
6Ryan JM, Tranah T, Mitry RR, et al. Acute liver failure in Ja- pan : definition, classification, and prediction of the outcome [ J ]. J Gastroenterol, 2012, 47 (8) : 849-861.
7Rocen M, Kieslichova E, Merta D, et al. The effect of prome- theus device on laboratory markers of inflammation and tissue re- generation in acute liver failure management [ J ]. Transplant Proc, 2010,42(9) : 3606-3611.
8Banares R, Catalina MV, Vaquero J. Liver support systems : will they ever reach prime time? [ J]. Curr Gastroenterol Rep, 2013, 15(3): 312.
9Rademacher S, Oppert M, Jorres A. Artificial extractor-poreal liver support therapy in patients with severe liver failure[ J]. Ex- pert Rev Gastroenterol Hepatol, 2011, 5 (5) : 591-599.
10Xu X, Liu X, Ling Q, et al. Artificial liver support system com- bined with liver transplantation in the treatment of patients with a- eute-on-chronie liver failure [ J ]. PLoS One, 2013, 8 ( 3 ) : e58738.
